These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2464708

  • 1. [Treatment of ovarian cancer].
    Kato T, Nishimura H.
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract] [Full Text] [Related]

  • 2. [Advances in the comprehensive treatment of ovarian cancer].
    Yakushiji M, Sugiyama T.
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1855-62. PubMed ID: 2454614
    [Abstract] [Full Text] [Related]

  • 3. [Changes in CA125 concentration in ovarian cancer patients during the remission state--mean attenuating curve and the effectiveness of surgery and chemotherapy].
    Kawai M, Inagaki S, Yamashita H, Imaizumi H, Kakihara M, Arii Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):537-42. PubMed ID: 2474041
    [Abstract] [Full Text] [Related]

  • 4. [VAB-3 chemotherapy of endodermal sinus tumor of the ovary].
    Goto Y, Imai K, Yamashita M, Konishi I, Fujii S, Noda Y, Okamura H, Mori T, Suzuki A.
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb 20; 22(1):75-80. PubMed ID: 2440967
    [No Abstract] [Full Text] [Related]

  • 5. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
    Pickel H.
    Gynakol Rundsch; 1989 Feb 20; 29 Suppl 2():357-8. PubMed ID: 2693256
    [No Abstract] [Full Text] [Related]

  • 6. Current status of the second-look operation in ovarian cancer.
    Schwartz PE.
    Clin Obstet Gynaecol; 1983 Aug 20; 10(2):245-59. PubMed ID: 6193920
    [No Abstract] [Full Text] [Related]

  • 7. [Significance of second look surgery in the therapy of ovarian cancer].
    Sasaki H, Ochiai K, Terashima Y.
    Gan No Rinsho; 1990 Aug 20; 36(10):1174-8. PubMed ID: 2214157
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ovarian cancer: what is poor prognosis disease?
    Cohen MH.
    J Clin Oncol; 1990 Jul 20; 8(7):1287-8. PubMed ID: 2113572
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
    Inagaki J, Ogawa M, Horikoshi N, Ezaki K, Inoue K, Aiba K, Komyo M, Miyamoto H, Ikeda K, Kubo H.
    Gan No Rinsho; 1983 Aug 20; 29(10):1291-5. PubMed ID: 6685195
    [Abstract] [Full Text] [Related]

  • 20. [Preliminary evaluation of the effectiveness of a modified treatment program in patients with malignant testicular neoplasms].
    Madej G, Siedlecki P, Meyza J.
    Pol Tyg Lek; 1983 Aug 20; 42(27-28):836-40. PubMed ID: 2446291
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.